In human glioblastoma cells (GBMs), RBBP4 depletion results in sensitization of tumor cells to temozolomide (TMZ) in conjunction with the downregulation of DNA repair protein Rad51 (54). The gene discussed is XRCC6P5; the disease is glioblastoma.